Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Alarum Technologies Ltd. and Certain Officers – ALAR
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Elastic N.V. and Certain Officers – ESTC
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers – WBA
-
Kaldalón hf.: Annual General Meeting - Final Agenda and Board Candidates
-
KOIL Energy Announces Delay in Filing of Annual Report on Form 10-K and anticipates reporting profitable growth in revenues
-
Ambia Solar Headquarters Move to Lindon, Utah
-
GivBux Details $212 Million Strategic Investment; Commits $212 Million to an Asset-Based Investment Vehicle
-
HII Celebrates 2024 Graduates of The Newport News Shipbuilding Apprentice School
-
Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Ris
-
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
-
Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual
-
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring
-
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requi
-
Saephan Companies Join the Unicorn Market: Johny Saephan Becomes First Mien-Thai American AI Billionaire with $1B Pre-Valuation Tied to Aisles Investment
-
Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
-
BexBack Launches 100x Leverage, Double Deposit Bonus, and $50 Welcome Bonus — No KYC Required
-
Imbria Presents Positive Clinical Data from Phase 2 IMPROVE-DiCE Trial of Ninerafaxstat in Patients with Cardiometabolic HFpEF at ACC.25
-
Ecom Brothers Launches New Done-for-You E-Commerce Growth Package to Empower Aspiring Entrepreneurs
-
ForexIGO by Avenix Fzco Enhances Automated Trading with Dual-Asset Precision
-
ExoraPad Presale Skyrockets, Raising Over 40,000 XRP – Could $EXP Outperform XRP Post-Launch?
-
Jostens Honors the Los Angeles Dodgers and their Eighth World Series Victory with a Spectacular Ring
-
Empowering Entrepreneurs: How Amazon Wealth Automation is Redefining E-Commerce Success
-
Water Mission Responding to Devastating Earthquake in Myanmar and Thailand
-
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
-
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
-
Osisko Development Reports Fourth Quarter and Year-End 2024 Results
-
Osisko Development Reports Fourth Quarter and Year-End 2024 Results
-
WiseChain.io Unveils AI-Powered Social Trading and Tailored Investment Solutions for Canadians and Seniors
-
Partners Value Split Corp. Announces 2024 Annual Results
-
Partners Value Investments L.P. Announces 2024 Annual Results
-
Partners Value Investments Inc. Announces 2024 Annual Results
-
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market
-
Safety Shot, Inc. Announces Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. - Updated
-
Avista reaches all-party, all issues settlement in Oregon general rate case
-
Senvest Capital Reports Results for the Year Ended December 31, 2024
-
Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results
-
Truss Faber Welcomes International Trade and Regulatory Attorney, Suzanne Garner
-
Knight Therapeutics Inc. ranks on The Globe and Mail’s sixth-annual Women Lead Here benchmark of executive gender diversity
-
Mulvihill Premium Yield Fund Announces Year End Results
-
Mulvihill Enhanced Split Preferred Share ETF Announces Year End Results
-
Rupert Resources Reports Audited Financial Results for the Ten Months Ending December 31, 2024
-
Premium Global Income Split Corp. Announces Year End Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
-
Coherent Announces General Availability of Industry-First 100G ZR QSFP28-DCO With High Optical Output Power
-
Purpose Investments Inc. Announces 2025 First-Quarter Distributions for Purpose Specialty Lending Trust
-
Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update
-
Coherent Announces General Availability of Industry-First 100G ZR QSFP28-DCO With High Optical Output Power
